{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:42:09Z","timestamp":1791225729293,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bpobgyn.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T06:50:33Z","timestamp":1459666233000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Anti-M\u00fcllerian hormone and polycystic ovary syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Priya","family":"Bhide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Homburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2016.03.004_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ijo.2008.61","article-title":"Polycystic ovary syndrome in adolescents","volume":"32","author":"Franks","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.bpobgyn.2016.03.004_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib4","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1136\/bmj.a2968","article-title":"Defining polycystic ovary syndrome","volume":"338","author":"Balen","year":"2009","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.bpobgyn.2016.03.004_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib6","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(18)37375-7","article-title":"Proteolytic processing of Mullerian inhibiting substance produces a transforming growth factor beta like fragment","volume":"263","author":"Pepinsky","year":"1988","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/molehr\/gat024","article-title":"Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection","volume":"19","author":"Jeppesen","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/humrep\/deq019","article-title":"Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles","volume":"25","author":"Andersen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum Mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovarian syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normo-ovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate marker for antral follicle count for definition of the polycystic ovarian syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bpobgyn.2016.03.004_bib14","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-M\u00fcllerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high?","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib18","first-page":"553","article-title":"Inhibitory effect of MAH upon the expression of aromatase and LH receptors by cultured granulose cells of rat and porcine immature ovaries","volume":"2","author":"Di Clemente","year":"1994","journal-title":"Endocrine"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/jc.2011-3133","article-title":"Differential regulation of ovarian anti-Mullerian hormone (AMH) by estradiol through \u03b1- and \u03b2-estrogen receptors","volume":"97","author":"Grynberg","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.fertnstert.2014.10.033","article-title":"Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antim\u00fcllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study","volume":"103","author":"Bhide","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","article-title":"The relationship between AMH, androgens, insulin resistance and basal ovarian status in non-obese subfertile women with and without polycystic ovarian syndrome","volume":"24","author":"Nardo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib23","article-title":"The role of anti-m\u00fcllerian hormone in the characterization of the different polycystic ovary syndrome phenotypes","author":"Romualdi","year":"2015","journal-title":"Reprod Sci"},{"issue":"8","key":"10.1016\/j.bpobgyn.2016.03.004_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/humrep\/dev131","article-title":"The phenotypic diversity in per-follicle anti-M\u00fcllerian hormone production in polycystic ovary syndrome","volume":"30","author":"M\u0160","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib25","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":". Androgens stimulate early stages of follicular growth in the primate ovary","volume":"10","author":"Vendola","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/dep049","article-title":"Androgen circle of polycystic ovary syndrome","volume":"24","author":"Homburg","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib27","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/deu242","article-title":"Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles","volume":"29","author":"Dewailly","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mulle- \u20ac rian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib30","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/dep074","article-title":"Anti-mullerian hormone concentrations in \u20ac androgen-suppressed women with polycystic ovary syndrome","volume":"24","author":"Carlsen","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0015-0282(03)00741-6","article-title":"Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting","volume":"80","author":"Hansen","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/uog.6310","article-title":"Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC","volume":"33","author":"Deb","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/uog.3913","article-title":"The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques","volume":"29","author":"Jayaprakasan","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1515\/cclm-2014-0022","article-title":"First fully automated immunoassay for anti-M\u00fcllerian hormone","volume":"52","author":"Gassner","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib38","series-title":"Access AMH instructions for use","author":"Beckman Coulter","year":"2014"},{"issue":"4","key":"10.1016\/j.bpobgyn.2016.03.004_bib39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antim\u00fcllerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.bpobgyn.2016.03.004_bib40","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.03.004_bib41","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.03.004_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/uog.11202","article-title":"Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?","volume":"40","author":"Catteau-Jonard","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2016.03.004_bib43","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","article-title":"Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism","volume":"95","author":"Dewailly","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1210\/jcem-70-1-11","article-title":"Serum levels of mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay","volume":"70","author":"Baker","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.repbio.2013.04.005","article-title":"Within-laboratory and between-laboratory variability in the measurement of anti-mullerian hormone determined within an external quality assurance scheme","volume":"13","author":"Zuvela","year":"2013","journal-title":"Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/humrep\/deu050","article-title":"Pre-mixing serum samples with assay buffer is a prerequisite for reproducible antimullerian hor- \u20ac mone measurement using the Beckman Coulter Gen II assay","volume":"29","author":"Han","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib47","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/des260","article-title":"Antimullerian hormone: poor assay reproducibility in a large cohort of sub- \u20ac jects suggests sample instability","volume":"27","author":"Rustamov","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in\u00a0vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.bpobgyn.2016.03.004_bib50","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","article-title":"The predictive value of circulating anti-Mullerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study","volume":"98","author":"Mahran","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2016.03.004_bib51","first-page":"1","article-title":"Limited ability of circulating anti-M\u00fcllerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays","author":"Vaiarelli","year":"2015","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2016.03.004_bib52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00404-015-3889-5","article-title":"Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria","volume":"293","author":"Jamil","year":"2016","journal-title":"Arch Gynecol Obstet"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416300025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693416300025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:38:35Z","timestamp":1655422715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693416300025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":52,"alternative-id":["S1521693416300025"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.03.004","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}